ACHV
Price
$3.79
Change
+$0.01 (+0.26%)
Updated
Dec 24 closing price
77 days until earnings call
ACLX
Price
$77.58
Change
+$0.79 (+1.03%)
Updated
Dec 24 closing price
84 days until earnings call
Ad is loading...

ACHV vs ACLX

Header iconACHV vs ACLX Comparison
Open Charts ACHV vs ACLXBanner chart's image
Achieve Life Sciences
Price$3.79
Change+$0.01 (+0.26%)
Volume$71.9K
CapitalizationN/A
Arcellx
Price$77.58
Change+$0.79 (+1.03%)
Volume$267.61K
CapitalizationN/A
ACHV vs ACLX Comparison Chart
Loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACHV vs. ACLX commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Buy and ACLX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Dec 26, 2024
Stock price -- (ACHV: $3.79 vs. ACLX: $77.58)
Brand notoriety: ACHV and ACLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 57% vs. ACLX: 44%
Market capitalization -- ACHV: $130.34M vs. ACLX: $4.2B
ACHV [@Biotechnology] is valued at $130.34M. ACLX’s [@Biotechnology] market capitalization is $4.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileACLX’s FA Score has 0 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • ACLX’s FA Score: 0 green, 5 red.
According to our system of comparison, ACLX is a better buy in the long-term than ACHV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 4 TA indicator(s) are bullish while ACLX’s TA Score has 4 bullish TA indicator(s).

  • ACHV’s TA Score: 4 bullish, 5 bearish.
  • ACLX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ACHV and ACLX are a bad buy in the short-term.

Price Growth

ACHV (@Biotechnology) experienced а -8.89% price change this week, while ACLX (@Biotechnology) price change was -5.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

Reported Earning Dates

ACHV is expected to report earnings on Mar 13, 2025.

ACLX is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.2B) has a higher market cap than ACHV($130M). ACLX YTD gains are higher at: 39.784 vs. ACHV (-8.010). ACHV has higher annual earnings (EBITDA): -29.95M vs. ACLX (-33.12M). ACLX has more cash in the bank: 574M vs. ACHV (42.9M). ACHV has less debt than ACLX: ACHV (9.85M) vs ACLX (65.3M). ACLX has higher revenues than ACHV: ACLX (156M) vs ACHV (0).
ACHVACLXACHV / ACLX
Capitalization130M4.2B3%
EBITDA-29.95M-33.12M90%
Gain YTD-8.01039.784-20%
P/E RatioN/AN/A-
Revenue0156M-
Total Cash42.9M574M7%
Total Debt9.85M65.3M15%
FUNDAMENTALS RATINGS
ACHV: Fundamental Ratings
ACHV
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACHVACLX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
89%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 7 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FLQL60.180.68
+1.14%
Franklin US Large Cap Mltfctr Idx ETF
IEDI54.620.52
+0.96%
iShares U.S. Consumer Focused ETF
DEW53.040.25
+0.48%
WisdomTree Global High Dividend ETF
EMQQ36.040.07
+0.19%
EMQQ The Emerging Markets Internet ETF
CADJPY109.39N/A
N/A
Canadian Dollar - Japan Yen

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with PLRX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
+0.26%
PLRX - ACHV
36%
Loosely correlated
+1.12%
FBIO - ACHV
35%
Loosely correlated
+4.02%
PGEN - ACHV
35%
Loosely correlated
+5.24%
DNLI - ACHV
35%
Loosely correlated
+0.67%
CRNX - ACHV
32%
Poorly correlated
-0.04%
More

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with DNLI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+1.03%
DNLI - ACLX
48%
Loosely correlated
+0.67%
BEAM - ACLX
48%
Loosely correlated
+0.38%
RCKT - ACLX
47%
Loosely correlated
+2.19%
RCUS - ACLX
47%
Loosely correlated
-0.31%
CRSP - ACLX
47%
Loosely correlated
+1.14%
More